163 results on '"Giuseppe Guida"'
Search Results
2. Phenotype overlap in the natural history of asthma
- Author
-
Fabio L.M. Ricciardolo, Giuseppe Guida, Francesca Bertolini, Antonino Di Stefano, and Vitina Carriero
- Subjects
Diseases of the respiratory system ,RC705-779 - Abstract
The heterogeneity of asthma makes it challenging to unravel the pathophysiologic mechanisms of the disease. Despite the wealth of research identifying diverse phenotypes, many gaps still remain in our knowledge of the disease's complexity. A crucial aspect is the impact of airborne factors over a lifetime, which often results in a complex overlap of phenotypes associated with type 2 (T2), non-T2 and mixed inflammation. Evidence now shows overlaps between the phenotypes associated with T2, non-T2 and mixed T2/non-T2 inflammation. These interconnections could be induced by different determinants such as recurrent infections, environmental factors, T-helper plasticity and comorbidities, collectively resulting in a complex network of distinct pathways generally considered as mutually exclusive. In this scenario, we need to abandon the concept of asthma as a disease characterised by distinct traits grouped into static segregated categories. It is now evident that there are multiple interplays between the various physiologic, cellular and molecular features of asthma, and the overlap of phenotypes cannot be ignored.
- Published
- 2023
- Full Text
- View/download PDF
3. Critical evaluation of asthma biomarkers in clinical practice
- Author
-
Giuseppe Guida, Diego Bagnasco, Vitina Carriero, Francesca Bertolini, Fabio Luigi Massimo Ricciardolo, Stefania Nicola, Luisa Brussino, Emanuele Nappi, Giovanni Paoletti, Giorgio Walter Canonica, and Enrico Heffler
- Subjects
asthma ,biomarkers ,airway inflammation ,eosinophils ,exhaled nitric oxide (FENO) ,sputum ,Medicine (General) ,R5-920 - Abstract
The advent of personalized medicine has revolutionized the whole approach to the management of asthma, representing the essential basis for future developments. The cornerstones of personalized medicine are the highest precision in diagnosis, individualized prediction of disease evolution, and patient-tailored treatment. To this aim, enormous efforts have been established to discover biomarkers able to predict patients' phenotypes according to clinical, functional, and bio-humoral traits. Biomarkers are objectively measured characteristics used as indicators of biological or pathogenic processes or clinical responses to specific therapeutic interventions. The diagnosis of type-2 asthma, prediction of response to type-2 targeted treatments, and evaluation of the risk of exacerbation and lung function impairment have been associated with biomarkers detectable either in peripheral blood or in airway samples. The surrogate nature of serum biomarkers, set up to be less invasive than sputum analysis or bronchial biopsies, has shown several limits concerning their clinical applicability. Routinely used biomarkers, like peripheral eosinophilia, total IgE, or exhaled nitric oxide, result, even when combined, to be not completely satisfactory in segregating different type-2 asthma phenotypes, particularly in the context of severe asthma where the choice among different biologics is compelling. Moreover, the type-2 low fraction of patients is not only an orphan of biological treatments but is at risk of being misdiagnosed due to the low negative predictive value of type-2 high biomarkers. Sputum inflammatory cell analysis, considered the highest specific biomarker in discriminating eosinophilic inflammation in asthma, and therefore elected as the gold standard in clinical trials and research models, demonstrated many limits in clinical applicability. Many factors may influence the measure of these biomarkers, such as corticosteroid intake, comorbidities, and environmental exposures or habits. Not least, biomarkers variability over time is a confounding factor leading to wrong clinical choices. In this narrative review, we try to explore many aspects concerning the role of routinely used biomarkers in asthma, applying a critical view over the “state of the art” and contemporarily offering an overview of the most recent evidence in this field.
- Published
- 2022
- Full Text
- View/download PDF
4. Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
- Author
-
Diego Bagnasco, Stefania Nicola, Elisa Testino, Luisa Brussino, Laura Pini, Marco Caminati, Federica Piccardo, Rikki Frank Canevari, Laura Melissari, Alessandro Ioppi, Luca Guastini, Carlo Lombardi, Manlio Milanese, Francesca Losa, Michela Robbiano, Laura De Ferrari, Anna Maria Riccio, Giuseppe Guida, Marco Bonavia, Donatella Fini, Francesco Balbi, Cristiano Caruso, Pierluigi Paggiaro, Francesco Blasi, Enrico Heffler, Giovanni Paoletti, Giorgio Walter Canonica, Gianenrico Senna, Giovanni Passalacqua, and on behalf of SANI
- Subjects
severe asthma ,eosinophils ,mepolizumab ,CRSwNP ,IL-5 ,real life ,Biology (General) ,QH301-705.5 - Abstract
The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from SANI (Severe Asthma Network Italy) clinics, we observed severe asthmatic patients treated with mepolizumab 100 mg/4 weeks, for a period of 3 years. 157 patients were observed. Exacerbations were reduced from the first year (−84.6%) and progressively to 90 and 95% in the second and third ones. Steroid-dependent patients decreased from 54% to 21% and subsequently to 11% in the second year and 6% in the third year. Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49% reduction in value from baseline to the third year. The study demonstrated the long-term efficacy of mepolizumab in a real-life setting.
- Published
- 2023
- Full Text
- View/download PDF
5. Emergency and spatial planning towards cooperative approaches
- Author
-
Adriana Galderisi, Giuseppe Guida, and Giada Limongi
- Subjects
emergency planning ,spatial planning ,multi-risk areas ,Transportation engineering ,TA1001-1280 ,Urbanization. City and country ,HT361-384 - Abstract
The dependency of risk scenarios on the dynamics of urban transformation clearly highlights the need of ensuring a closer cooperation between spatial and emergency planning processes. So far the relationships between these processes have been rather limited, leading at most to the transposition of the emergency plans' indications in the spatial plans. Nevertheless, more cooperative approaches would be crucial to increase safety, resilience and sustainability of human settlements, above all when the latter are threatened by different hazard factors. In order to explore barriers and opportunities for a better cooperation between emergency and spatial planning tools, this contribution will focus on the Campi Flegrei in the Campania Region (Southern Italy): an area densely populated, hosting a significant historical, cultural, and natural heritage, and prone to volcanic, seismic and hydrogeological hazards. The case study area is also characteized by the coexistence of emergency and spatial planning tools acting on different spatial scales, developed by different actors and not always fully consistent each other. In detail, based on the in-depth analysis of the location and accessibility of emergency facilities, crucial to guarantee an effective response in the aftermath of hazardous events, we will here highlight both the main criticalities of the emergency plans recently carried out for the selected Municipalities and the difficulties and opportunities related to a better integration between spatial and emergency planning at municipal scale.
- Published
- 2021
- Full Text
- View/download PDF
6. Cutaneous allergic reaction correlates with anti‐erythropoietin antibodies in dialysis patient developing pure red cell aplasia
- Author
-
Iuliana Badiu, Davide Diena, Giuseppe Guida, Carlo Ferrando, Davide Rapezzi, and Luca Besso
- Subjects
allergy tests ,anti‐erythropoietin antibodies ,erythropoetin allergy ,pure red cell aplasia ,Medicine ,Medicine (General) ,R5-920 - Abstract
Abstract We describe a case of concomitant erythropoietin allergy and resistance with a possible IgE and IgG‐mediated immune response, in which the local allergic cutaneous symptoms preceded the antibody‐mediated anemia.
- Published
- 2022
- Full Text
- View/download PDF
7. Nasal Cytology: A Easy Diagnostic Tool in Precision Medicine for Inflammation in Epithelial Barrier Damage in the Nose. A Perspective Mini Review
- Author
-
Cristiano Caruso, Rossana Giancaspro, Giuseppe Guida, Alberto Macchi, Massimo Landi, Enrico Heffler, and Matteo Gelardi
- Subjects
nasal cytology ,biomarker ,precision medicine ,NARES ,non-allergic rhinitis ,chronic rhinosinusitis ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Nasal cytology is a diagnostic tool that can be used in precision rhinology medicine. Particularly in non-allergic rhinitis and chronic rhinosinusitis forms it can be useful to evaluate biomarkers of both surgical or biological therapy and especially in the follow-up it must be used to predict the prognostic index of recurrence of nasal polyposis. All inflammatory cytokines are also linked to the presence of cells such as eosinophils and mastcells and nasal cytology is a non-invasive and repeatable method to assess the situation in real life.
- Published
- 2022
- Full Text
- View/download PDF
8. Severe asthma: One disease and multiple definitions
- Author
-
Diego Bagnasco, MD, PhD, Pierluigi Paggiaro, MD, Manuela Latorre, MD, Chiara Folli, BS, Elisa Testino, MD, Arianna Bassi, MD, Manlio Milanese, MD, Enrico Heffler, MD, Andrea Manfredi, Anna Maria Riccio, BS, Laura De Ferrari, BS, Francesco Blasi, Rikki Frank Canevari, MD, Giorgio Walter Canonica, MD, Giovanni Passalacqua, MD, Gabriella Guarnieri, Vincenzo Patella, Foschino Barbaro Maria Pia, Giovanna Elisiana Carpagnano, Anna del Colle, Giulia Scioscia, Pelaia Gerolamo, Francesca Puggioni, Francesca Racca, Elisabetta Favero, Sandra Iannacone, Eleonora Savi, Marcello Montagni, Gianna Camiciottoli, Chiara Allegrini, Carlo Lombardi, Giuseppe Spadaro, Caterina Detoraki, Francesco Menzella, Carla Galeone, Patrizia Ruggiero, Monna Rita Yacoub, Alvise Berti, Nicola Scichilone, Carmen Durante, Maria Teresa Costantino, Chiara Roncallo, Mariachiara Braschi, Alice D’Adda, Erminia Ridolo, Massimo Triggiani, Roberta Parente, D’Amato Maria, Maria Vittoria Verrillo, Giovanni Rolla, Luisa Brussino, Agata Valentina Frazzetto, Zappa Maria Cristina, Marianna Lilli, Nunzio Crimi, Marco Bonavia, Angelo Guido Corsico, Amelia Grosso, Stefano Del Giacco, Margherita Deidda, Luisa Ricciardi, Stefania Isola, Francesca Cicero, Giuliana Amato, Federica Vita, Antonio Spanevello, Patrizia Pignatti, Francesca Cherubino, Dina Visca, Fabio Luigi Massimo Ricciardolo, Vitina Maria Anna Carriero, Francesca Bertolini, Pierachille Santus, Roberta Barlassina, Andrea Airoldi, Giuseppe Guida, Nucera Eleonora, Arianna Aruanno, Angela Rizzi, Cristiano Caruso, Stefania Colantuono, Gianenrico Senna, Marco Caminati, Alessandra Arcolaci, Andrea Vianello, Fulvia Chieco Bianchi, Maria Rita Marchi, Stefano Centanni, Simone Luraschi, Silvia Ruggeri, Rocco Rinaldo, Elena Parazzini, Cecilia Calabrese, Martina Flora, Lorenzo Cosmi, Linda Di Pietro, Enrico Maggi, Laura Pini, Luigi Macchia, Danilo Di Bona, Luca Richeldi, Carola Condoluci, Leonello Fuso, Matteo Bonini, Alessandro Farsi, Giulia Carli, Paolo Montuschi, Giuseppe Santini, Maria Elisabetta Conte, Elisa Turchet, Carlo Barbetta, Francesco Mazza, Simona D’Alo, Stefano Pucci, Maria Filomena Caiaffa, Elena Minenna, Luciana D'Elia, Carlo Pasculli, Vittorio Viviano, Paolo Tarsia, Joyce Rolo, Mariacarmela Di Proietto, and Salvatore Lo Cicero
- Subjects
Severe asthma ,Classification ,Definition ,Biological treatment ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Introduction: There is, so far, no universal definition of severe asthma. This definition usually relies on: number of exacerbations, inhaled therapy, need for oral corticosteroids, and respiratory function. The use of such parameters varies in the different definitions used. Thus, according to the parameters chosen, each patient may result in having severe asthma or not. The aim of this study was to evaluate how the choice of a specific definition of severe asthma can change the allocation of patients. Methods: Data collected from the Severe Asthma Network Italy (SANI) registry were analyzed. All the patients included were then reclassified according to the definitions of U-BIOPRED, NICE, WHO, ATS/ERS, GINA, ENFUMOSA, and TENOR. Results: 540 patients, were extracted from the SANI database. We observed that 462 (86%) met the ATS/ERS criteria as well as the GINA criteria, 259 (48%) the U-Biopred, 222 (41%) the NICE, 125 (23%) the WHO, 313 (58%) the Enfumosa, and 251 (46%) the TENOR criteria. The mean eosinophil value were similar in the ATS/ERS, U-Biopred, and Enfumosa (528, 532 and 516 cells/mcl), higher in WHO and Tenor (567 and 570 cells/mcl) and much higher in the NICE classification (624 cells/mcl). Lung function tests resulted similarly in all groups, with WHO (67%) and ATS/ERS-GINA (73%), respectively, showing the lower and upper mean FEV1 values. Conclusions: The present observations clearly evidence the heterogeneity in the distribution of patients when different definitions of severe asthma are used. However, the recent definition of severe asthma, provided by the GINA document, is similar to that indicated in 2014 by ATS/ERS, allowing mirror reclassification of the patients examined. This lack of homogeneity could complicate the access to biological therapies. The definition provided by the GINA document, which reflects what suggested by ATS/ERS, could partially overcome the problem.
- Published
- 2021
- Full Text
- View/download PDF
9. Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
- Author
-
Stefano Levra, Giuseppe Guida, Andrea Elio Sprio, Flavio Crosa, Paolo Carlo Ghio, Francesca Bertolini, Vitina Carriero, Carlo Albera, and Fabio Luigi Massimo Ricciardolo
- Subjects
pirfenidone ,nintedanib ,real-life ,idiopathic pulmonary fibrosis ,Biology (General) ,QH301-705.5 - Abstract
Pirfenidone and nintedanib are the only two drugs approved for the treatment of idiopathic pulmonary fibrosis (IPF). Both proved to be safe and well-tolerated in clinical trials, but real-world data and direct comparisons are scarce. This real-life study explored the safety profile of pirfenidone and nintedanib with a prolonged follow-up. We retrospectively collected clinical status, adverse events (AEs), and treatment changes from IPF patients who had started an antifibrotic treatment at our centre from December 2011 to December 2020, including 192 patients treated with pirfenidone and 89 with nintedanib. The majority of patients in both groups experienced one or more AEs during the follow-up. A higher proportion of AEs in the nintedanib group were effectively treated with behavioural modifications or additional medications compared with the pirfenidone group (52.5% vs. 40.6%, p = 0.04). Overall, a difference in the impact of AEs due to nintedanib versus pirfenidone resulted in a lower permanent discontinuation of therapy (8.3% vs. 18.3%, p = 0.02), with the latter being associated with a higher risk of drug discontinuation at 48 months after initiation (OR = 2.52, p = 0.03). Our study confirms the safety profile of antifibrotic drugs in IPF but highlights that AEs due to nintedanib are usually easier to manage and lead to fewer cases of permanent discontinuation of therapy.
- Published
- 2022
- Full Text
- View/download PDF
10. Rebuilding of the Burial Environment from the Chemical Biography of Archeological Copper-Based Artifacts
- Author
-
Gabriel M. Ingo, Cristina Riccucci, Giuseppe Guida, Monica Albini, Chiara Giuliani, and Gabriella Di Carlo
- Subjects
Chemistry ,QD1-999 - Published
- 2019
- Full Text
- View/download PDF
11. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
- Author
-
Diego Bagnasco, Massimiliano Povero, Lorenzo Pradelli, Luisa Brussino, Giovanni Rolla, Marco Caminati, Francesco Menzella, Enrico Heffler, Giorgio Walter Canonica, Pierluigi Paggiaro, Gianenrico Senna, Manlio Milanese, Carlo Lombardi, Caterina Bucca, Andrea Manfredi, Rikki Frank Canevari, Giovanni Passalacqua, Gabriella Guarnieri, Vincenzo Patella, Foschino Barbaro Maria Pia, Elisiana Carpagnano, Anna del Colle, Giulia Scioscia, Pelaia Gerolamo, Manuela Latorre, Francesca Puggioni, Francesca Racca, Elisabetta Favero, Sandra Iannacone, Eleonora Savi, Marcello Montagni, Gianna Camiciottoli, Chiara Allegrini, Giuseppe Spadaro, Caterina Detoraki, Carla Galeone, Patrizia Ruggiero, Monna Rita Yacoub, Alvise Berti, Gisella Colombo, Nicola Scichilone, Carmen Durante, Maria Teresa Costantino, Chiara Roncallo, Mariachiara Braschi, Francesco Blasi, Alice D'Adda, Erminia Ridolo, Massimo Triggiani, Roberta Parente, D'Amato Maria, Maria Vittoria Verrillo, Zappa Maria Cristina, Marianna Lilli, Nunzio Crimi, Marco Bonavia, Angelo Guido Corsico, Amelia Grosso, Stefano Del Giacco, Margherita Deidda, Luisa Ricciardi, Stefania Isola, Francesca Cicero, Giuliana Amato, Federica Vita, Antonio Spanevello, Patrizia Pignatti, Francesca Cherubino, Dina Visca, Eleonora Aletti, Fabio Luigi Massimo Ricciardolo, Vitina Maria Anna Carriero, Francesca Bertolini, Pierachille Santus, Roberta Barlassina, Andrea Airoldi, Giuseppe Guida, Nucera Eleonora, Arianna Aruanno, Angela Rizzi, Cristiano Caruso, Stefania Colantuono, Alessandra Arcolaci, Andrea Vianello, Fulvia Chieco Bianchi, Maria Rita Marchi, Stefano Centanni, Simone Luraschi, Silvia Ruggeri, Rocco Rinaldo, Elena Parazzini, Cecilia Calabrese, Martina Flora, Lorenzo Cosmi, Linda Di Pietro, Enrico Maggi, Laura Pini, Luigi Macchia, Danilo Di Bona, Luca Richeldi, Carola Condoluci, Leonello Fuso, Matteo Bonini, Alessandro Farsi, Giulia Carli, Paolo Montuschi, Giuseppe Santini, Maria Elisabetta Conte, Elisa Turchet, Carlo Barbetta, Francesco Mazza, Simona D'Alo, Stefano Pucci, Maria Filomena Caiaffa, Elena Minenna, Luciana D'Elia, Carlo Pasculli, Vittorio Viviano, Paolo Tarsia, Joyce Rolo, Mariacarmela Di Proietto, and Salvatore Lo Cicero
- Subjects
Severe asthma ,Mepolizumab ,Anti IL-5 ,Pharmacoeconomics ,OCS ,Comorbidities ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Background and aims: Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patients. Methods: Patients >18 years old, referred to 8 asthma clinics, starting MEP between May 2017 and December 2018, were enrolled and followed-up for 12 months. Information in the 12 months before mepolizumab were collected retrospectively. The evaluation parameters included: OCS use, number of exacerbations/hospitalizations, concomitant therapies, comorbidity, and annual number of working days lost due to the disease. The primary objective was to compare the annual total cost per patient pre- and post-MEP. Secondary outcomes included rates of exacerbations and number of OCS-dependent patients. Results: 106 patients were enrolled in the study: 46 male, median age 58 years. Mean annual cost pre- and post-MEP (cost of biologic excluded) was €3996 and €1,527, respectively. Total savings due to MEP resulted in €2469 (95%CI 1945–2993), 62% due to exacerbations reduction and 33% due to productivity increase. Such savings could fund about 22% of the total cost of MEP for one year. The introduction of MEP induced a clinical benefit by reducing both OCS-dependent patients (OR = 0.12, 95%CI 0.06–0.23) and exacerbation rate (RR = 0.19, 95%CI 0.15–0.24). Conclusions: Patients with severe eosinophilic asthma experienced a clinical benefit in asthma control adding MEP to standard therapy. Biologic therapy can be, partially, funded by the savings produced by patients’ improvement.
- Published
- 2021
- Full Text
- View/download PDF
12. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
- Author
-
Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, Gianenrico Senna, Giovanni Passalacqua, Antonio Spanevello, Stefano Aliberti, Diego Bagnasco, Marco Bonavia, Matteo Bonini, Luisa Brussino, Caterina Bucca, Maria F. Caiaffa, Cecilia Calabrese, Gianna Camiciottoli, Marco Caminati, Giovanna E. Carpagnano, Cristiano Caruso, Stefano Centanni, Maria E. Conte, Angelo G. Corsico, Lorenzo Cosmi, Maria T. Costantino, Nunzio Crimi, Simona D’Alò, Maria D'Amato, Stefano Del Giacco, Alessandro Farsi, Elisabetta Favero, Maria P. Foschino Barbaro, Gabriella Guarnieri, Giuseppe Guida, Manuela Latorre, Salvatore Lo Cicero, Carlo Lombardi, Luigi Macchia, Francesco Mazza, Francesco Menzella, Manlio Milanese, Marcello Montagni, Paolo Montuschi, Eleonora Nucera, Roberta Parente, Vincenzo Patella, Girolamo Pelaia, Laura Pini, Francesca Puggioni, Luisa Ricciardi, Fabio L.M. Ricciardolo, Luca Richeldi, Erminia Ridolo, Giovanni Rolla, Pierachille Santus, Nicola Scichilone, Giuseppe Spadaro, Andrea Vianello, Vittorio Viviano, Mona R. Yacoub, Maria C. Zappa, and Enrico Heffler
- Subjects
Severe asthma ,Biologics ,Oral corticosteroids ,Real-life ,Registr ,Immunologic diseases. Allergy ,RC581-607 - Abstract
According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored all alternatives currently available for a large part of severe asthmatics.
- Published
- 2020
- Full Text
- View/download PDF
13. Efficacy of Mepolizumab in patients with previous Omalizumab treatment failure: real life observation
- Author
-
Diego Bagnasco, Francesco Menzella, Marco Caminati, Cristiano Caruso, Giuseppe Guida, Marco Bonavia, Anna Maria Riccio, Manlio Milanese, Gianenrico Senna, and Giovanni Passalacqua
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2020
- Full Text
- View/download PDF
14. Investigating gilding techniques on Gandharan stone sculptures and architectural components: a preliminary note
- Author
-
Marco Zaminga, Ivana Angelini, Massimo Vidale, Luca Maria Olivieri, and Giuseppe Guida
- Subjects
Architecture ,NA1-9428 ,Archaeology ,CC1-960 - Abstract
A series of samples taken from gilded Gandharan sculpted objects in schist (both portable artifacts and architectural decorative components), coming from different sacred sites of ancient Gandhara and the Swat valley, are in the course of analytical inspection. They are studied by the means of different archaeometric techniques. Although, given the precarious conservation and rarity of the objects available for analysis, our preliminar results cannot be generalized, the emerging evidence is discussed in the light of the gilding technologies so far described in other cultural areas and periods. It is also argued that, in the Gandharan cultual complexes, the surface of sacred images might be covered with diverging procedures, dictated by various technical and/or religious concerns.
- Published
- 2019
- Full Text
- View/download PDF
15. Polychromy and gilding in the Gandharan sculptures from Pakistan and Afghanistan: samplings from Museum Guimet in Paris, Civic Archaeological Museum of Milan and Museum of Oriental Art of Turin
- Author
-
Simona Pannuzi, Fabio Talarico, Giuseppe Guida, and Carlo Rosa
- Subjects
polychromy ,gilding ,stucco arteworks ,clay arteworks ,chemical analyses ,Gandharan art ,Architecture ,NA1-9428 ,Archaeology ,CC1-960 - Abstract
This paper will discuss the scientific results of a recent sampling of the polychrome and gilded stone, stucco and clay sculptures of Gandharan art not yet published. Four years ago, we had the opportunity to begin an articulated research project focused on the Gandharan polychrome stone and stucco sculptures, and in the last two years, thanks to a very limited grant, offered by the Italian Government to the Istituto Superiore per la Conservazione ed il Restauro (ISCR), we had the opportunity to develop a new research. This allowed us to investigate some important artefacts displayed in these Museums: the Archaeological Museum of Milan, the Museum of Oriental Art of Turin, the Museum Guimet in Paris. Moreover, we had the opportunity to take some archaeological samples from the new excavations of the Italian Archaeological Mission in Pakistan and the Italian Archaeological Mission in Afghanistan. In this new research we analysed the artistic technique of painting and gilding on sculptures of Gandharan art made in different materials (stone, stucco and clay). The results discussed in this paper comes from a notable number of chemical analyses (optical stero-microscope, SEM-EDS, micro-FTIR, micro-XRD and micro-Raman).
- Published
- 2019
- Full Text
- View/download PDF
16. Eosinophilic Phenotype: The Lesson from Research Models to Severe Asthma
- Author
-
Giuseppe, Guida, primary and Andrea, Antonelli, additional
- Published
- 2020
- Full Text
- View/download PDF
17. Made in sud. L'industria tra intervento pubblico e territorio dilapidato
- Author
-
Giuseppe Guida, Francesco Gastaldi, Guida, Giuseppe, and Gastaldi, Francesco
- Subjects
aree industriali, politiche di sviluppo, Mezzogiorno, rigenerazione urbana ,Pharmacology (medical) - Abstract
The policies supporting southern Italy, implemented since the Second World War o the end of the twentieth century, have contributed to reducing the gap whit the North of the country but these regions are still experiencing difficulties that are unresolved from a political and socio-economic point of view. This condition is reflected in the territorial forms, whose crisis today demands, from an urban planning point of view, pertinent reading and solution models of a strategic type and a regenerative approach. The framework that is traced with regard to public intervention in the South is centered on the role of three actors: big industry and the State, with their reciprocal intermingling, and the southern territorial milieu. From the territorial point of view, a critical relationship between the large industrial areas and the territories of medium and small towns around which the large production 'plates' were implanted, in particular, the Industrial Development Areas, was determined, among other outcomes. Through the case study of the province of Caserta, we suggest the need for an adequate analytical framework and a replicable regenerative approach where rural identities, abandonment, the historical palimpsest and a still persistent industrial vocation vie with each other, affecting the territory's future prospects
- Published
- 2022
- Full Text
- View/download PDF
18. La ricerca accademica per le aree interne
- Author
-
Giuseppe Guida, Adriana Galderisi, and Guida, Giuseppe
- Subjects
Ricerca, aree interne, urbanistica - Published
- 2023
19. Exhaled nitric oxide in asthma: from diagnosis to management
- Author
-
Giuseppe Guida, Vitina Carriero, Francesca Bertolini, Stefano Pizzimenti, Enrico Heffler, Giovanni Paoletti, and Fabio L.M. Ricciardolo
- Subjects
Breath Tests ,Exhalation ,Immunology ,Immunology and Allergy ,Humans ,Nitric Oxide ,Glucocorticoids ,Asthma ,Biomarkers - Abstract
Exhaled nitric oxide (FENO) is a noninvasive marker of eosinophilic airway inflammation, therefore, highly informative in asthma. Although FENO measurement is a potentially accessible tool to many physicians, recommendations regarding its clinical utility in diagnosing or tailoring treatment have not reached the expected diffusion. More recently FENO emerged as a biomarker for type-2 asthma phenotyping and a predictor of response to biologics.The physiological discoveries and relevant acquisitions in clinical practice regarding FENO in asthma are presented. The FENO story draw a wavy path, characterized by promising findings, exciting confirmations and periods of low visibility. FENO emerged as a tool to increase the probability of asthma diagnosis. FENO predicts response to inhaled glucocorticoids (ICS), favoring the development of tailored treatment strategies and unrevealing nonadherence to ICS in difficult-to-treat or uncontrolled asthma. Finally, FENO was associated with a more severe phenotype and became a consolidated biomarker of type-2 inflammation.FENO demonstrated to be a noninvasive and very reproducible test, encompassing many applications in the field of asthma management. Its routinely use, according to international guidelines, may improve the quality of patient assistance, from difficult-to-treat cases to biologic monitoring.
- Published
- 2023
20. Co-progettare con le comunità locali: il ruolo dei Living Labs
- Author
-
Giuseppe Guida, Adriana Galderisi, A. Galderisi, and Guida, Giuseppe
- Subjects
Living Lab, aree interne, urbanistica - Abstract
Il ruolo della partecipazione e dei Living Lab nei processi di pianificazione per le aree interne
- Published
- 2023
21. Il processo di partecipazione
- Author
-
Giuseppe Guida, Valentina Vittiglio, Adriana Galderisi, A. Galderisi, Guida, Giuseppe, and Vittiglio, Valentina
- Subjects
Partecipazione, Living Labs, urbanistica - Published
- 2023
22. From research questions to define a new urban
- Author
-
Giuseppe Guida, Giuseppe Guida, and Guida, Giuseppe
- Subjects
urban planning, industrial areas, periurban, regeneration - Abstract
Un'analisi dei contesti periurbani del Meridione in relazione alle Aree di Sviluppo Industriale, con un approfondimento del caso casertano.
- Published
- 2022
23. The case of ASI Caserta. Urban metabolism and spatial relations
- Author
-
Giuseppe Guida, Giuseppe Guida, G. Guida, and Guida, Giuseppe
- Subjects
industrial, regeneration, ASI, Caserta - Abstract
Il caso dell'Area di Sviluppo Industriale di Caserta e il rapporto con il territorio e i contesti urbani ed agricoli
- Published
- 2022
24. Planning strategies and eco-innovative solutions for new lands_Design examples for the three sample study areas
- Author
-
Giuseppe Guida, Valentina Vittiglio, Giuseppe Guida, G. Guida, Guida, Giuseppe, and Vittiglio, Valentina
- Abstract
Visioni progettuali tra periurbano e aree industriali nel casertano
- Published
- 2022
25. COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
- Author
-
Stefania Nicola, Richard Borrelli, Irene Ridolfi, Virginia Bernardi, Paolo Borrelli, Giuseppe Guida, Andrea Antonelli, Carlo Albera, Stefania Marengo, Antonio Briozzo, Claudio Norbiato, Agata Valentina Frazzetto, Marina Saad, Luca Lo Sardo, Beatrice Bacco, Silvia Gallo Cassarino, Stefano Della Mura, Diego Bagnasco, Caterina Bucca, Giovanni Rolla, Paolo Solidoro, and Luisa Brussino
- Subjects
SARS-CoV-2 ,respiratory failure ,Medicine (miscellaneous) ,COVID-19 ,asthma ,COVID-19 outcomes ,OCS ,respiratory support ,ICS ,COPD ,biologics ,inhaled corticosteroids - Abstract
Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities.
- Published
- 2022
26. Do the current guidelines for asthma pharmacotherapy encourage over-treatment?
- Author
-
Stefania Nicola, Giuseppe Guida, Giovanni Paoletti, Giovanni Passalacqua, Luisa Brussino, Enrico Heffler, Cristiano Caruso, Elisa Calzolari, Diego Bagnasco, Laura De Ferrari, and Giorgio Walter Canonica
- Subjects
Allergen immunotherapy ,medicine.medical_specialty ,education ,MEDLINE ,Inhaled corticosteroids ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Medicine ,Asthmatic patient ,Over treatment ,Pharmacology (medical) ,Intensive care medicine ,Asthma ,Pharmacology ,business.industry ,allergen immunotherapy ,GINA ,ICS/formoterol ,inhaled corticosteroids ,mild asthma ,steroids side effects ,General Medicine ,medicine.disease ,respiratory tract diseases ,Airway disease ,030220 oncology & carcinogenesis ,business ,030217 neurology & neurosurgery - Abstract
Asthma is a common airway disease, affecting worldwide a percentage of people between 1% and 18%. Although the proper management of asthmatic patients should be ensured by following international d...
- Published
- 2020
- Full Text
- View/download PDF
27. Manufactured in the Peri-Urban: Regenerative Strategies for Critical Lands
- Author
-
Giuseppe Guida, L. Amenta, M. Russo, A. van Timmeren, and Guida, Giuseppe
- Subjects
Peri-urban, Industrial areas, Eco-innovative solutions, Regenerative city - Abstract
Peri-urban is an intermediate land. On the one hand, its hybrid nature makes it particularly vulnerable to speculation, indiscriminate use of soil resources, erosion of agricultural residues, and so on; on the other hand, it is difficult to control through planning instruments and policies. Starting from this background, the chapter will investigate the territories of the large Campania Plain, in the South of Italy, between Naples and Caserta. Until the middle of twentieth century, this territory was known as Campania Felix due to its agricultural vocation. Subsequently, a series of development policies and a misinterpreted concept of valorization and modernization of the territory have changed its characteristics and identity, giving many parts of it to disorder: industrial settlements, plants, logistics, landfills, and large infrastructures that clash with the residential, agricultural, or residual areas and in-between natural ones. In this context, the chapter summarizes the first results of a research project that aims to rethink the role of the large Industrial Development Areas, established in the peri-urban contexts of the plain in the province of Caserta, in Italy.
- Published
- 2022
28. Pianificare l’incerto. Un laboratorio di urbanistica sui territori della crisi urbana e industriale
- Author
-
Giuseppe Guida, Valentina Vittiglio, Guida, Giuseppe, and Vittiglio, Valentina
- Subjects
Rigenerazione urbana, laboratorio di urbanistica, aree industriali - Abstract
Una riflessione sull'approccio didattico alla progettazione urbanistica a partire dalle aree industriali degradate ed in abbandono.
- Published
- 2022
29. BEYOND ALL LIMITS
- Author
-
Giuseppe Guida, Adriana Galderisi, Giada Limongi, Giovanni Bello, Valentina Vittiglio, A. Galderisi, G. Guida, G. Limongi, V. Vittiglio, G. Bello, C. Gambardella, Guida, Giuseppe, Galderisi, Adriana, Limongi, Giada, Bello, Giovanni, and Vittiglio, Valentina
- Published
- 2022
30. 7 pezzi facili. Viaggio breve nella Napoli interrotta
- Author
-
Giuseppe Guida, Antonio Di Gennaro, Guida, Giuseppe, and Di Gennaro, Antonio
- Subjects
paesaggio, Napoli, strategie, urbanistica, rigenerazione urbana - Abstract
Una lettura urbanistica e paesaggistica di alcuni luoghi critici della metropoli napoletana
- Published
- 2022
31. Pianura on the Edge
- Author
-
Giuseppe Guida, Attilio Belli, A. Belli, and Guida, Giuseppe
- Subjects
Napoli, paesaggi, periferia, Pianura, urbanistica - Published
- 2022
32. Comunità resilienti e strategia di resistenza dei territori
- Author
-
Adriana Galderisi, Giuseppe Guida, Galderisi, Adriana, and Guida, Giuseppe
- Subjects
Aree interne, resilienza, urbanistica - Abstract
L’ampio tema delle aree interne della Penisola trova nel Meridione specificità che spesso non emergono e che, ancora più spesso, le politiche nazionali non intercettano. Il Ministero della Transizione Ecologica ha finanziato la ricerca RIPROVARE, che ha approfondito tre contesti territoriali del Sud: l’alto Casertano e l’Ufita, in Campania e l’ambito del Medio Agri in Basilicata, facendo emergere alcune priorità dal dialogo con i territori, attraverso partecipazione e Living Lab.
- Published
- 2022
33. Paesaggi a rischio e paesaggi del rischio. Indirizzi per accrescere la resilienza
- Author
-
Adriana Galderisi, Giuseppe Guida, AA. VV., A. Attademo, E. Formato, M. Russo, Galderisi, Adriana, and Guida, Giuseppe
- Subjects
Rischio, Resilienza, Landscape urbanism, pianificazione territoriale, paesaggi - Abstract
Le condizioni di rischio e la trasformazione dei paesaggi in Campania.
- Published
- 2022
34. Nomi, luoghi e identità. Note per una nuova geografia delle aree interne
- Author
-
Giuseppe Guida, Giuseppe Guida, F. D. Moccia, M. Sepe, and Guida, Giuseppe
- Subjects
Aree interne, urbanistica, inner areas - Published
- 2021
35. Rischio liquido. Pianificare il periurbano tra paesaggi dello scarto e flussi di rifiuti
- Author
-
Giuseppe Guida, Giuseppe Guida, A. Galderisi, M. di Venosa, G. Fera, S. Menoni, and Guida, Giuseppe
- Subjects
Rischio, pianificazione, paesaggio - Published
- 2020
36. Pianificazione di emergenza e pianificazione urbanistica in Campania: un focus sull’area metropolitana di Napoli
- Author
-
Adriana Galderisi, Giuseppe Guida, Giada Limongi, Adriana Galderisi, Giuseppe Guida, Giada Limongi, M. Francini, A. Palermo, M. F. Viapiana, Galderisi, Adriana, Guida, Giuseppe, Limongi, Giada, AA.VV., and Mauro Francini, Annunziata Palermo, Maria Francesca Viapiana
- Subjects
Risk, Urban Planning, Emergency Plans - Published
- 2020
37. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
- Author
-
Liang-Wen Hang, Karrinda Kenny, Louis-Philippe Boulet, Jane Duke, Désirée Larenas-Linnemann, Claude S. Farah, Mónica De Gennaro, Peter A. B. Wark, Hubertus Jersmann, Maria Teresa Costantino, Dermot Ryan, Mark Hew, Vanessa M. McDonald, Mohammad Hashim Khan, Pin-Kuei Fu, Mitesh Patel, Majdy Idrees, David A. Jackson, Violina Vasileva, Constance H. Katelaris, Matthew Masoli, Nunzio Crimi, Celeste Porsbjerg, Janet Rimmer, Veronica Lawriwskyj, Ying-Chun Chien, Norma Linaker, Sally E. Wenzel, Alan Altraja, Ricardo Campos, Carlos Torres-Duque, Manlio Milanese, Enrico Heffler, Eleftherios Zervas, Andréanne Côté, Guy Brusselle, Alan James, Luis Perez-de-Llano, Jorge Maspero, David Langton, Francesca Puggioni, Mona Al-Ahmad, Riyard Al-Lehebi, Adel H. Mansur, Tom Brown, José Luis Miguel, Chris Corrigan, Arnaud Bourdin, James Fingleton, Brian J. Lipworth, Shrikant Pawar, Paula Kauppi, Philip G. Bardin, Alexandra Nanzer-Kelly, Carlos Andrés Celis-Preciado, Santus Pierachille, David Price, George Christoff, Pauline Hughes, Hitashi Rupani, João Fonseca, Nikolaos G. Papadopoulos, Naghmeh Radhakrishna, Lauri Lehtimäki, Rekha Chaudhuri, Anne-Maree Cheffins, Tara Mackenzie, Christian Taube, Kenneth R. Chapman, Charlotte Suppli Ulrik, Giorgio Walter Canonica, Mariko Koh Siyue, Maria Elisabetta Conte, Giovanna Elisiana Carpagnano, Chantal E. Le Lievre, Mohsen Sadatsafavi, Unnur S. Bjornsdottir, Praveen Akuthota, Mark FitzGerald, Andrew Menzies-Gow, Jaideep Dhariwal, Stelios Loukides, Michael E. Wechsler, Paul E Pfeffer, Matthew J. Peters, Giuseppe Guida, Zinta Harrington, Konstantinos Kostikas, Ian Clifton, Tze Lee Tan, Andriana I. Papaioannou, Li Ping Chung, John W. Upham, Parameswaran Nair, John Harrington, Aikaterini Detoraki, Liam G Heaney, Roberta Parente, Paul M. O'Byrne, Jo A Douglass, Kanok Pipatvech, Ming-Ju Tsai, Caterina Bucca, Vibeke Backer, Peter Middleton, Patrick Mitchell, Paddy Dennison, Luisa Ricciardi, Njira L Lugogo, Job F M van Boven, Flavia C.L. Hoyte, Stephen J. Fowler, Gregory Katsoulotos, Bassam Mahboub, Rovira Francisco, Nicola A. Hanania, John Corless, Mona-Rita Yacoub, Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), and Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
- Subjects
medicine.medical_specialty ,Exacerbation ,[SDV]Life Sciences [q-bio] ,Delphi method ,Biologics ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Randomized controlled trial ,law ,medicine ,Immunology and Allergy ,Asthma ,Asthma treatment ,Consensus ,Delphi Technique ,Humans ,Surveys and Questionnaires ,Quality of Life ,030212 general & internal medicine ,Intensive care medicine ,ComputingMilieux_MISCELLANEOUS ,business.industry ,Minimal clinically important difference ,medicine.disease ,3. Good health ,030228 respiratory system ,Asthma Control Questionnaire ,Allergists ,business - Abstract
Background Clinicians are increasingly recognizing severe asthma patients in whom biologics and other add-on therapies lead to dramatic improvement. Currently, there is no agreed-upon super-responder (SR) definition. Objective To survey severe asthma experts using a modified Delphi process, to develop an international consensus-based definition of a severe asthma SR. Methods The Delphi panel was composed of 81 participants (94% specialist pulmonologists or allergists) from 24 countries and consisted of three iterative online voting rounds. Consensus on individual items, whether acceptance or rejection, required at least 70% agreement by panel members. Results Consensus was achieved that the SR definition should be based on improvement across three or more domains assessed over 12 months. Major SR criteria included exacerbation elimination, a large improvement in asthma control (two or more times the minimal clinically important difference), and cessation of maintenance of oral steroids (or weaning to adrenal insufficiency). Minor SR criteria were composed of a 75% exacerbation reduction, having well-controlled asthma, and 500 mL or greater improvement in FEV1. The SR definition requires improvement in at least two major criteria. In the future, the SR definition should be expanded to incorporate quality of life measures, although current tools can be difficult to implement in a clinical setting and further research is needed. Conclusions This international consensus-based definition of severe asthma SRs is an important prerequisite for better understanding SR prevalence, predictive factors, and the mechanisms involved. Further research is needed to understand the patient's perspective and to measure quality of life more precisely in SRs.
- Published
- 2021
- Full Text
- View/download PDF
38. TEACHING EXPERIENCES FOR IMPROVING STUDENTS' ENVIRONMENTAL AWARENESS
- Author
-
Nicola Pisacane, Caterina Frettoloso, Rossella Franchino, Giuseppe Guida, Autori vari, L. Gómez Chova, A. López Martínez, I. Candel Torres, Franchino, R., Frettoloso, C., Guida, G., and Pisacane, N.
- Published
- 2021
- Full Text
- View/download PDF
39. Territories in the Middle of the Ford. Mapping and Knowledge for Nature-Based Approach in the South Italy
- Author
-
Giovanni Bello, Giuseppe Guida, Valentina Vittiglio, Guida, Giuseppe, Bello, Giovanni, and Vittiglio, Valentina
- Subjects
industrial area ,Urban agglomeration ,Process (engineering) ,eco-solutions ,Geography, Planning and Development ,0211 other engineering and technologies ,Nature based ,TJ807-830 ,02 engineering and technology ,010501 environmental sciences ,Management, Monitoring, Policy and Law ,TD194-195 ,01 natural sciences ,Renewable energy sources ,urban planning ,Brownfield ,Urban planning ,regenerative landscape ,Regional science ,eco-solution ,GE1-350 ,mapping ,0105 earth and related environmental sciences ,Environmental effects of industries and plants ,Renewable Energy, Sustainability and the Environment ,business.industry ,021107 urban & regional planning ,Building and Construction ,industrial areas ,Environmental sciences ,Identification (information) ,Industrialisation ,Geography ,Agriculture ,business - Abstract
The paper investigates a particular phenomenon of the industrialization of Southern Italy, starting from the second post-war period, and, in particular, the unsolved relationship between some large industrial areas and the territories of the medium and small cities on which such productive “plates” have been installed. The town planning policies and instruments with which the industrialization of Southern Italy was planned, on the contrary, foresaw a strong integration between urban fabric and industrial agglomerations. Through the case study of the province of Caserta, the research illustrated by the paper investigates, first of all, the policies that supported this process of industrialization and what the territorial effects of this phenomenon were. Next, the paper illustrates the method of knowledge and mapping of the territory of the case study of the industrial development area of Caserta. The data will be collected in a GIS platform that will return the following condition that is nowadays not available: analytical maps of the brownfield areas and the identification of the areas still intact, agricultural or green areas, urban areas and infrastructures, which trace a cognitive framework addressed to the project in which it will possible to experiment some possible eco-innovative and nature-based solutions.
- Published
- 2021
40. Segni di speranza nella Terra dei fuochi
- Author
-
Giuseppe Guida and Guida, Giuseppe
- Subjects
regolamento urbanistico, sostenibilità, rigenerazione urbana - Published
- 2021
41. Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma
- Author
-
Giacomo Malipiero, Giuseppe Spriano, Corrado Pelaia, Francesca Racca, Sebastian Ferri, Luca Malvezzi, Giulio Melone, Alessia Mariani, Francesca Puggioni, Giuseppe Guida, Enrico Heffler, Giovanni Paoletti, Francesca Pirola, and Giorgio Walter Canonica
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Inflammation ,Nitric Oxide ,01 natural sciences ,Gastroenterology ,Airway inflammation ,Asthma ,Chronic rhinosinusitis with nasal polyps ,Exhaled nitric oxide ,Nitric oxide ,Pulmonary function testing ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Nasal Polyps ,Internal medicine ,medicine ,Humans ,Nasal polyps ,Sinusitis ,Rhinitis ,business.industry ,010401 analytical chemistry ,respiratory system ,Middle Aged ,medicine.disease ,respiratory tract diseases ,0104 chemical sciences ,Respiratory Function Tests ,030228 respiratory system ,chemistry ,Breath Tests ,Concomitant ,Case-Control Studies ,Chronic Disease ,Quality of Life ,Female ,medicine.symptom ,Airway ,business - Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex inflammatory disease highly impacting patient's quality of life, and associated with lower airway inflammation often evolving into asthma. Exhaled nitric oxide (FENO) is a non-invasive tool to assess Type 2 airway inflammation and its extended analysis allows to differentiate between alveolar concentration (CalvNO) and bronchial output (JawNO). It is also possible to assess the sino-nasal production of nitric oxide (nNO). We studied extended nitric oxide production in patients with CRSwNP with or without associated asthma. Consecutive adult patients with CRSwNP, with or without asthma, and 15 healthy controls were enrolled. Exclusion criteria were: smoking, uncontrolled asthma, recent upper or lower airway infections and oral corticosteroid therapy in the 4 weeks preceding clinical evaluation. Patients' demographic and clinical data were collected; patients underwent pulmonary function tests and extended nitric oxide analysis including nasal nNO assessment. A total of 125 subjects were enrolled (15 healthy controls; 69 with CRSwNP and asthma, and 41 with CRSwNP only). FENO, JawNO and CalvNO values were higher, while nNO was lower, in all patients with CRSwNP compared to healthy controls; no difference was found in CalvNO between patients with concomitant asthma and non-asthmatic subjects; in asthmatic patients, FENO and JawNO were significantly higher, while nNO values was lower, compared to patients with CRSwNP only. These results suggest that CRSwNP could be the first manifestation of a more complex systemic inflammatory pathology driven by Type 2 inflammation. An 'inflammatory gradient' hypothesis could describe a pattern of inflammation in CRSwNP patients that starts distally in the alveoli. Finally, our study indirectly reinforces the concept that novel biological drugs could become valid therapeutic options for nasal polyposis.
- Published
- 2021
42. Severe asthma: One disease and multiple definitions
- Author
-
Maria Teresa Costantino, Luigi Macchia, Angelo Corsico, Andrea Airoldi, Carla Galeone, Zappa Maria Cristina, Paolo Tarsia, Foschino Barbaro Maria Pia, Silvia Ruggeri, Pierluigi Paggiaro, Lorenzo Cosmi, A. Farsi, Vitina Maria Anna Carriero, Arianna Bassi, Francesca Bertolini, Giovanni Passalacqua, Fulvia Chieco Bianchi, Carlo Lombardi, Salvatore Lo Cicero, Giovanni Rolla, Carmen Durante, Rocco Rinaldo, Elena Parazzini, Arianna Aruanno, Maria Rita Marchi, Chiara Folli, Alessandra Arcolaci, Carlo Pasculli, Fabio Luigi Massimo Ricciardolo, Vittorio Viviano, Alvise Berti, Stefano Del Giacco, Andrea Manfredi, Roberta Barlassina, Agata Valentina Frazzetto, Pierachille Santus, Luisa Brussino, Anna del Colle, Marco Bonavia, Dina Visca, Nicola Scichilone, Patrizia Pignatti, Enrico Heffler, Francesca Racca, Giuseppe Santini, Nucera Eleonora, Giovanna Elisiana Carpagnano, Linda Di Pietro, Stefano Centanni, Maria Elisabetta Conte, Vincenzo Patella, Monna Rita Yacoub, Diego Bagnasco, Nunzio Crimi, Anna Maria Riccio, Stefania Isola, Margherita Deidda, Gabriella Guarnieri, Giuseppe Guida, Elena Minenna, Manuela Latorre, Gianna Camiciottoli, Maria Vittoria Verrillo, Luca Richeldi, Marcello Montagni, Francesca Cicero, Maria Filomena Caiaffa, Antonio Spanevello, Cecilia Calabrese, Carlo Barbetta, Elisabetta Favero, Gianenrico Senna, Giuliana Amato, Amelia Grosso, Federica Vita, Francesco Blasi, Luisa Ricciardi, Carola Condoluci, Massimo Triggiani, Enrico Maggi, Mariacarmela Di Proietto, Giulia Carli, Roberta Parente, Eleonora Savi, Chiara Roncallo, Paolo Montuschi, Luciana D'Elia, Francesco Mazza, Simona D’Alo, Patrizia Ruggiero, Francesca Puggioni, Matteo Bonini, Simone Luraschi, Francesco Menzella, Leonello Fuso, Marco Caminati, Martina Flora, Mariachiara Braschi, Cristiano Caruso, Angela Rizzi, Sandra Iannacone, Rikki Frank Canevari, Andrea Vianello, D’Amato Maria, Manlio Milanese, Stefania Colantuono, Giorgio Walter Canonica, Giulia Scioscia, Laura Pini, Elisa Testino, Erminia Ridolo, Joyce Rolo, Elisa Turchet, Pelaia Gerolamo, Danilo Di Bona, Laura De Ferrari, Francesca Cherubino, Alice D’Adda, Marianna Lilli, Giuseppe Spadaro, Stefano Pucci, Caterina Detoraki, Chiara Allegrini, Bagnasco, D., Paggiaro, P., Latorre, M., Folli, C., Testino, E., Bassi, A., Milanese, M., Heffler, E., Manfredi, A., Riccio, A. M., De Ferrari, L., Blasi, F., Canevari, R. F., Canonica, G. W., Passalacqua, G., Guarnieri, G., Patella, V., Maria Pia, F. B., Carpagnano, G. E., Colle, A. D., Scioscia, G., Gerolamo, P., Puggioni, F., Racca, F., Favero, E., Iannacone, S., Savi, E., Montagni, M., Camiciottoli, G., Allegrini, C., Lombardi, C., Spadaro, G., Detoraki, C., Menzella, F., Galeone, C., Ruggiero, P., Yacoub, M. R., Berti, A., Scichilone, N., Durante, C., Costantino, M. T., Roncallo, C., Braschi, M., D'Adda, A., Ridolo, E., Triggiani, M., Parente, R., Maria, D. A., Verrillo, M. V., Rolla, G., Brussino, L., Frazzetto, A. V., Cristina, Z. M., Lilli, M., Crimi, N., Bonavia, M., Corsico, A. G., Grosso, A., Del Giacco, S., Deidda, M., Ricciardi, L., Isola, S., Cicero, F., Amato, G., Vita, F., Spanevello, A., Pignatti, P., Cherubino, F., Visca, D., Massimo Ricciardolo, F. L., Anna Carriero, V. M., Bertolini, F., Santus, P., Barlassina, R., Airoldi, A., Guida, G., Eleonora, N., Aruanno, A., Rizzi, A., Caruso, C., Colantuono, S., Senna, G., Caminati, M., Arcolaci, A., Vianello, A., Bianchi, F. C., Marchi, M. R., Centanni, S., Luraschi, S., Ruggeri, S., Rinaldo, R., Parazzini, E., Calabrese, C., Flora, M., Cosmi, L., Di Pietro, L., Maggi, E., Pini, L., Macchia, L., Di Bona, D., Richeldi, L., Condoluci, C., Fuso, L., Bonini, M., Farsi, A., Carli, G., Montuschi, P., Santini, G., Conte, M. E., Turchet, E., Barbetta, C., Mazza, F., D'Alo, S., Pucci, S., Caiaffa, M. F., Minenna, E., D'Elia, L., Pasculli, C., Viviano, V., Tarsia, P., Rolo, J., Di Proietto, M., Lo Cicero, S., Bagnasco D., Paggiaro P., Latorre M., Folli C., Testino E., Bassi A., Milanese M., Heffler E., Manfredi A., Riccio A.M., De Ferrari L., Blasi F., Canevari R.F., Canonica G.W., Passalacqua G., Guarnieri G., Patella V., Maria Pia F.B., Carpagnano G.E., Colle A.D., Scioscia G., Gerolamo P., Puggioni F., Racca F., Favero E., Iannacone S., Savi E., Montagni M., Camiciottoli G., Allegrini C., Lombardi C., Spadaro G., Detoraki C., Menzella F., Galeone C., Ruggiero P., Yacoub M.R., Berti A., Scichilone N., Durante C., Costantino M.T., Roncallo C., Braschi M., D'Adda A., Ridolo E., Triggiani M., Parente R., Maria D.A., Verrillo M.V., Rolla G., Brussino L., Frazzetto A.V., Cristina Z.M., Lilli M., Crimi N., Bonavia M., Corsico A.G., Grosso A., Del Giacco S., Deidda M., Ricciardi L., Isola S., Cicero F., Amato G., Vita F., Spanevello A., Pignatti P., Cherubino F., Visca D., Massimo Ricciardolo F.L., Anna Carriero V.M., Bertolini F., Santus P., Barlassina R., Airoldi A., Guida G., Eleonora N., Aruanno A., Rizzi A., Caruso C., Colantuono S., Senna G., Caminati M., Arcolaci A., Vianello A., Bianchi F.C., Marchi M.R., Centanni S., Luraschi S., Ruggeri S., Rinaldo R., Parazzini E., Calabrese C., Flora M., Cosmi L., Di Pietro L., Maggi E., Pini L., Macchia L., Di Bona D., Richeldi L., Condoluci C., Fuso L., Bonini M., Farsi A., Carli G., Montuschi P., Santini G., Conte M.E., Turchet E., Barbetta C., Mazza F., D'Alo S., Pucci S., Caiaffa M.F., Minenna E., D'Elia L., Pasculli C., Viviano V., Tarsia P., Rolo J., Di Proietto M., Lo Cicero S., Bagnasco, D, Paggiaro, P, Latorre, M, Folli, C, Testino, E, Bassi, A, Milanese, M, Heffler, E, Manfredi, A, Riccio, A, De Ferrari, L, Blasi, F, Frank Canevari, R, Canonica, G, Passalacqua, G, Guarnieri, G, Patella, V, Foschino Barbaro, M, Carpagnano, G, del Colle, A, Scioscia, G, Gerolamo, P, Puggioni, F, Racca, F, Favero, E, Iannacone, S, Savi, E, Montagni, M, Camiciottoli, G, Allegrini, C, Lombardi, C, Spadaro, G, Detoraki, C, Menzella, F, Galeone, C, Ruggiero, P, Yacoub, R, Verrillo, M, Rolla, G, and Lo Cicero, S
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Severe asthma ,Immunology ,Nice ,Disease ,Settore MED/10 - Malattie Dell'Apparato Respiratorio ,Article ,Pulmonary function testing ,Internal medicine ,Biological treatment ,Classification ,Definition ,medicine ,Immunology and Allergy ,Respiratory function ,computer.programming_language ,Biological therapies ,business.industry ,Settore MED/09 - MEDICINA INTERNA ,RC581-607 ,Severe asthma, Classification, Definition, Biological treatment ,Biological treatment, Classification, Definition, Severe asthma ,Immunologic diseases. Allergy ,business ,computer - Abstract
Introduction There is, so far, no universal definition of severe asthma. This definition usually relies on: number of exacerbations, inhaled therapy, need for oral corticosteroids, and respiratory function. The use of such parameters varies in the different definitions used. Thus, according to the parameters chosen, each patient may result in having severe asthma or not. The aim of this study was to evaluate how the choice of a specific definition of severe asthma can change the allocation of patients. Methods Data collected from the Severe Asthma Network Italy (SANI) registry were analyzed. All the patients included were then reclassified according to the definitions of U-BIOPRED, NICE, WHO, ATS/ERS, GINA, ENFUMOSA, and TENOR. Results 540 patients, were extracted from the SANI database. We observed that 462 (86%) met the ATS/ERS criteria as well as the GINA criteria, 259 (48%) the U-Biopred, 222 (41%) the NICE, 125 (23%) the WHO, 313 (58%) the Enfumosa, and 251 (46%) the TENOR criteria. The mean eosinophil value were similar in the ATS/ERS, U-Biopred, and Enfumosa (528, 532 and 516 cells/mcl), higher in WHO and Tenor (567 and 570 cells/mcl) and much higher in the NICE classification (624 cells/mcl). Lung function tests resulted similarly in all groups, with WHO (67%) and ATS/ERS-GINA (73%), respectively, showing the lower and upper mean FEV1 values. Conclusions The present observations clearly evidence the heterogeneity in the distribution of patients when different definitions of severe asthma are used. However, the recent definition of severe asthma, provided by the GINA document, is similar to that indicated in 2014 by ATS/ERS, allowing mirror reclassification of the patients examined. This lack of homogeneity could complicate the access to biological therapies. The definition provided by the GINA document, which reflects what suggested by ATS/ERS, could partially overcome the problem.
- Published
- 2021
43. Delirious Napoli. Informales und illegales Vorgehen als urbanistische Taktik
- Author
-
Giuseppe Guida, Federica Vingelli, Guida, Giuseppe, and Vingelli, Federica
- Abstract
Die Beziehung zwischen Neapel und der Stadtplanung, also jener Disziplin, die sich mit der Betrachtung und Steuerung der physischen, sozialen und wirtschaftlichen Dimension einer Stadt befasst, war schon immer sehr widersprüchlich. Historisch haben die Menschen – die Arbeiter*innen, Handwerker*innen, Tagelöhner*innen, Kleinkriminellen, Gelegenheitsdiebe (auf Neapolitanisch die mariuoli), Schwerverbrecher*innen, camorristi und Ma!osi, Politiker* innen, Ladenbesitzer*innen, bis hin zu den Schuhputzerjungen (sciuscià im gleichnamigen Film von Vittorio De Sica, ein neapolitanisches Wort, abgeleitet vom amerikanischen shoe-shine), haben Lastenträger*innen, Drogendealer*innen und Müßiggänger*innen aller Art und jeden Geschlechts die großen Umwälzungen und städtebaulichen Regeln mit einer Art Gleichgültigkeit und Fatalismus erlebt, der es ihnen erlaubte, sich anzupassen und, wenn möglich, davon zu pro!tieren. So hat sich alles von selbst geregelt. Kleine Grundstückseigentümer* innen, Grundbesitzer*innen, Bauunternehmer*innen, städtische Techniker*innen und Politiker*innen auf allen Ebenen haben sich selbst die Regeln und Gelegenheiten gegeben, die ihnen am günstigsten erschienen. Ganze Stadtteile Neapels sind auf diese Weise entstanden: Wo der Bebauungsplan besagte, dass nicht gebaut werden darf, wurde es dennoch einfach gemacht.
- Published
- 2021
44. Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome)
- Author
-
Alfredo Vannacci, Christian Dejaco, Carlo Manno, Paolo Fraticelli, Elisa Tinazzi, Giacomo Emmi, Giuseppe Paolazzi, Roberto Bortolotti, Paolo Fabbrini, Paolo Delvino, Johann Willeit, Matteo Piga, Angela Padula, Giuseppe Lopalco, Marco Pellecchio, Franco Franceschini, Armando Gabrielli, Pietro Leccese, Lorenzo Delfino, Mara Felicetti, Federica Maritati, Guido Jeannin, Vito Racanelli, Milena Bond, Simone Negrini, Federico Alberici, Peter Willeit, Stefano Polti, Maria Rita Marchi, Roberto Padoan, Franco Schiavon, Alvise Berti, Giulia Pazzola, Loredana Colla, Paola Tomietto, Augusto Vaglio, Paola Toniati, Iuliana Badiu, Sara Monti, Roberto Caporali, Chiara Marvisi, Giuseppe Guida, Savino Sciascia, Enrica Bozzolo, Adriana Cariddi, Domenico Prisco, Iacopo Olivotto, Claudio Lunardi, Fabrizio Conti, Lorenzo Dagna, Alberto Cauli, Luca Quartuccio, Renato Alberto Sinico, Alessandra Palmisano, Florenzo Iannone, Maria Letizia Urban, Silvia Tamanini, Alessandra Bortoluzzi, Roberta Priori, Carlomaurizio Montecucco, Vincenzo Venerito, Federica Furini, Gina Gregorini, Alessandra Bettiol, Carlo Selmi, Martina Tedesco, Angelo Vacca, Carlo Salvarani, Gabriella Moroni, Giovanni Rolla, Marcello Govoni, Silvano Bettio, Maria Rosa Pozzi, and Stefan Kiechl
- Subjects
medicine.medical_specialty ,education.field_of_study ,Proportional hazards model ,business.industry ,Population ,Birmingham Vasculitis Activity Score ,Lower risk ,medicine.disease ,Internal medicine ,Cohort ,Eosinophilic ,medicine ,Granulomatosis with polyangiitis ,education ,business ,Cohort study - Abstract
Background and objectiveSystemic small vessel vasculitides carry an increased risk of acute arterial and venous thromboembolic events (AVTE); however, this risk has not been systematically explored in Eosinophilic Granulomatosis with Polyangiitis (EGPA). This study assessed the occurrence and main risk factors of AVTE among EGPA patients as compared to the general community from the population-based Bruneck cohort.MethodsWe conducted a retrospective multicenter cohort study on 573 EGPA patients. Clinical and serological data were collected at diagnosis. Occurrence of AVTE and time to the first AVTE after EGPA diagnosis were recorded. Age-standardized event rate (SER) of AVTE as compared to the reference cohort was assessed. Cox regression was applied to identify AVTE predictors.Results129 EGPA patients (22.5%) had AVTE, considered as potentially life-threatening in 55.8%. Seventy patients experienced an AVTE prior to diagnosis (of whom 58.6% in the two years before diagnosis) and 75 following EGPA diagnosis, of whom 56% in the two subsequent years. The SER of AVTE as compared to the reference cohort was 2.10 (95% CI 1.67-2.63). This risk was particularly increased in patients with history of AVTE and with a Birmingham Vasculitis Activity Score ≥20 at diagnosis. Patients receiving immunosuppression within 2 months of diagnosis were at lower risk, while antiplatelet or anticoagulant treatment did not confer measurable benefit.ConclusionEGPA is associated with AVTE in approximately one quarter of patients, particularly around diagnosis. Immunosuppressants seemed to exert a protective effect, while anticoagulant and antiplatelet agents did not.
- Published
- 2020
- Full Text
- View/download PDF
45. Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
- Author
-
Giorgio Piacentini, Mauro Maniscalco, Enrico Heffler, Giovanni Paoletti, Giovanna Elisiana Carpagnano, Vincenza Pezzella, Elisabetta Favero, Andrea Motta, Eugenio Baraldi, Giovanni Rolla, Giuseppe Guida, and Stefano Nardini
- Subjects
Pulmonary and Respiratory Medicine ,Spirometry ,medicine.medical_specialty ,Allergy ,Clinical immunology ,Fractional exhaled nitric oxide (FE ,Population ,Asthma diagnosis ,Disease ,) ,NO ,03 medical and health sciences ,0302 clinical medicine ,medicine ,030212 general & internal medicine ,Intensive care medicine ,education ,Asthma ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,fungi ,food and beverages ,Asthma management ,medicine.disease ,Fractional Exhaled Nitric Oxide (FENO) ,respiratory tract diseases ,030228 respiratory system ,Exhaled nitric oxide ,Position paper ,Position Paper ,business ,asthma management - Abstract
Asthma prevalence in Italy is on the rise and is estimated to be over 6% of the general population. The diagnosis of asthma can be challenging and elusive, especially in children and the last two decades has brought evidences that asthma is not a single disease but consists of various phenotypes. Symptoms can be underestimated by the patient or underreported to the clinician and physical signs can be scanty. Usual objective measures, like spirometry, are necessary but sometimes not significant. Despite proper treatment asthma can be a very severe condition (even leading to death) however new drugs have recently become available which can be very effective in its control. Since asthma is currently thought to be caused by inflammation, a direct measure of the latter can be of paramount importance. For this purpose, the measurement of Fractional Exhaled Nitric Oxide (FENO) has been used since the early years of the current century as a non-invasive, easy-to-assess tool useful for diagnosing and managing asthma. This SIP-IRS/SIAAIC Position Paper is a narrative review which summarizes the evidence behind the usefulness of FENO in the diagnosis, management and phenotypization of asthma.
- Published
- 2020
- Full Text
- View/download PDF
46. The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life
- Author
-
Maria D'Amato, Manlio Milanese, Cristiano Caruso, Alessandro Massolo, Francesco Menzella, Anna Maria Riccio, Giovanni Paoletti, Marco Caminati, Caterina Bucca, Gianenrico Senna, Elisa Testino, Giorgio Walter Canonica, Laura De Ferrari, Luisa Brussino, Carlo Lombardi, Diego Bagnasco, Giovanni Rolla, Giovanni Passalacqua, Enrico Heffler, Marco Bonavia, and Giuseppe Guida
- Subjects
severe asthma ,medicine.medical_specialty ,asthma, mepolizumab ,eosinophil count ,Severe asthma ,Immunology ,MEDLINE ,Antibodies, Monoclonal, Humanized ,real life ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,In real life ,Anti-Asthmatic Agents ,Asthma ,business.industry ,mepolizumab ,outcome ,correlation ,asthma ,medicine.disease ,Eosinophils ,Blood eosinophils ,business ,Mepolizumab ,medicine.drug - Published
- 2020
47. Defining a severe asthma super-responder: findings from a Delphi process
- Author
-
Delphi panel: Adel Mansur, Aikaterini, Detoraki, Alan, Altraja, Alan, James, Alexandra, Nanzer-Kelly, Andréanne, Côté, Andrew, Menzies-Gow, Andriana, Papaioannou, Anne-Maree, Cheffins, Arnaud, Bourdin, Bassam, Mahboub, Brian, Lipworth, Carlos Andrés Celis-Preciado, Carlos, Torres-Duque, Caterina, Bucca, Celeste, Porsbjerg, Charlotte, Ulrik, Chris, Corrigan, Christian, Taube, Claude, Farah, Constance, Katelaris, David, Langton, Dermot, Ryan, Désirée, Larenas-Linnemann, Eleftherios, Zervas, Enrico, Heffler, Flavia, Hoyte, Francesca, Puggioni, George, Christoff, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Giuseppe, Guida, Gregory, Katsoulotos, Guy, Brusselle, Hitashi, Rupani, Hubertus, Jersmann, Ian, Clifton, Jaideep, Dhariwal, James, Fingleton, Jane, Duke, Janet, Rimmer, Douglass, Jo, João, Fonseca, Job van Boven, John, Corless, John, Harrington, Jorge, Maspero, José Luis Miguel, Kanok, Pipatvech, Karrinda, Kenny, Kenneth, Chapman, Konstantinos, Kostikas, Lauri, Lehtimäki, Li Ping Chung, Liam, Heaney, Liang-Wen, Hang, Louis-Philippe, Boulet, Luis, Perez-de-Llano, Ricciardi, Luisa, Majdy, Idrees, Manlio, Milanese, Maria Elisabetta Conte, Maria Teresa Costantino, Mariko Koh Siyue, Mark, Fitzgerald, Mark, Hew, Matthew, Peters, Ming-Ju, Tsai, Mitesh, Patel, Mohammad Hashim Khan, Mohsen, Sadatsafavi, Mona, Al-Ahmad, Mona-Rita, Yacoub, Mónica De Gennaro, Naghmeh, Radhakrishna, Nicola Alexander Hanania, Nikolaos, Papadopoulos, Njira, Lugogo, Norma, Linaker, Nunzio, Crimi, Paddy, Dennison, Parameswaran, Nair, Patrick David Mitchell, Paul, O’Byrne, Paul, Pfeffer, Paula, Kauppi, Pauline, Hughes, Peter, Middleton, Peter, Wark, Philip, Bardin, Pin-Kuei, Fu, Praveen, Akuthota, Rekha, Chaudhuri, Ricardo, Campos, Riyard, Al-Lehebi, Roberta, Parente, Rovira, Francisco, Sally, Wenzel, Santus, Pierachille, Shrikant, Pawar, Stelios, Loukides, Stephen, Fowler, Tara, Mackenzie, Thomas, Brown, Tze Lee Tan, Unnur, Björnsdóttir, Vanessa, Mcdonald, Veronica, Lawriwskyj, Vibeke, Backer, Violina, Vasileva, Ying-Chun, Chien, and Zinta, Harrington.
- Published
- 2020
48. Tooth grooves, occlusal striations, dental calculus, and evidence for fiber processing in an Italian eneolithic/bronze age cemetery
- Author
-
Luca Bondioli, Serena Vaccaro, David W. Frayer, Alessandra Sperduti, Giuseppe Guida, Pierpaolo Petrone, Paola Rossi, and Maria Rita Giuliani
- Subjects
Adult ,Male ,Adolescent ,education ,High resolution ,Anthropology, Physical ,Young Adult ,Severe attrition ,stomatognathic system ,Bronze Age ,Calculus ,Humans ,Cemeteries ,Dental Calculus ,0601 history and archaeology ,Control sample ,Child ,History, Ancient ,Cannabis ,060101 anthropology ,060102 archaeology ,Textiles ,06 humanities and the arts ,Chalcolithic ,Middle Aged ,Biological materials ,stomatognathic diseases ,Italy ,Child, Preschool ,Anthropology ,Female ,Tooth Wear ,Anatomy ,Tooth ,Geology - Abstract
OBJECTIVES We conducted a systematic macroscopic and microscopic examination of occlusal and para-occlusal wear in a large dental sample (n = 3,014) from 217 individuals dated to the Early Bronze age site of Gricignano d'Aversa, Italy. We used macroscopic and microscopic techniques to document nondietary occlusal and para-occlusal wear and to analyze calculus inclusions in some of the teeth. In combining an analysis of the wear with the calculus inclusions we linked the specific wear to the likely fiber that was involved in producing it. MATERIALS AND METHODS Teeth and their high resolution epoxy casts were analyzed through SEM and reflected light microscopes. Nineteen individuals (fifteen with activity induced dental modifications and four as a control sample) were examined for the presence of calculus inclusions. RESULTS Activity induced dental modifications (AIDMs), notches, grooves and micro-striations, were found in the 62.2% of the adult females, in 21.2% of the adults of unknown sex and in a single male. We found the full spectrum of dental manipulations from very minor nonocclusal wear in some young individuals to severe attrition at the other extreme. The width of the striations and grooves, mostly on the upper incisors, suggests a craft activity involving fibers and thread production and manipulation. From the dental calculus of two females with grooves and striations, we extracted three fragments of fibers, identified as hemp (Cannabis, sp.). Previously from Gricignano woven hemp fibers were found on both surfaces of a metal blade associated with a male burial. DISCUSSION This study found the co-occurrence of tooth AIDMs and the actual fibers preserved in the dental calculus. As more work is done analyzing dental calculus in a variety of humans, it is apparent that this biological material holds rich resources documenting non-dietary habits.
- Published
- 2018
- Full Text
- View/download PDF
49. A Preliminary Note on the Metallography and Chemical Analysis of Silver Samples from the Mahboubian Collection, London
- Author
-
Massimo Vidale, Rosangela Faieta, and Giuseppe Guida
- Subjects
Cultural Studies ,060102 archaeology ,General Arts and Humanities ,media_common.quotation_subject ,Metallurgy, silver-copper alloy, gunagi vessels, Sukkalmah dynasty, Iran ,silver-copper alloy ,06 humanities and the arts ,Art ,Iran ,010502 geochemistry & geophysics ,01 natural sciences ,Archaeology ,language.human_language ,Anthropology ,2nd millennium BC ,Metallurgy ,Sukkalmah dynasty ,Metallography ,Elamite language ,language ,0601 history and archaeology ,gunagi vessels ,Inscribed figure ,0105 earth and related environmental sciences ,media_common - Abstract
This is the chemico-physical examination of 13 samples collected from the early 2nd millennium BC Linear Elamite inscribed silver gunagi vessels of the Mahboubian collection (see Desset; preceding ...
- Published
- 2018
- Full Text
- View/download PDF
50. Pianificare nella Terra dei Fuochi. Il caso del PUC di Capodrise
- Author
-
Giuseppe Guida, Rassegna Urbanistica Nazionale, and Guida, Giuseppe
- Subjects
piano, urbanistica, aree degradate, progetto urbano - Abstract
L'abstract sintetizza un percorso di piano urbanistico comunale sostenibile, resiliente e a consumo di suolo "0", integrato da alcuni affondi progettuali per definire e prefigurare la forma dei alcuni aree specifiche del comune di Capodrise guardate nello scenario dell'ambito periurbano del casertano.
- Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.